- Home
- DGII vs HROW Comparison
DGII vs HROW Comparison
Compare DGII & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGII
- HROW
- Stock Information
- Founded
- DGII 1985
- HROW 1998
- Country
- DGII United States
- HROW United States
- Employees
- DGII N/A
- HROW N/A
- Industry
- DGII Computer peripheral equipment
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- DGII Technology
- HROW Health Care
- Exchange
- DGII Nasdaq
- HROW Nasdaq
- Market Cap
- DGII 1.3B
- HROW 1.4B
- IPO Year
- DGII N/A
- HROW N/A
- Fundamental
- Price
- DGII $38.11
- HROW $45.38
- Analyst Decision
- DGII Buy
- HROW Strong Buy
- Analyst Count
- DGII 4
- HROW 7
- Target Price
- DGII $38.75
- HROW $64.67
- AVG Volume (30 Days)
- DGII 202.0K
- HROW 535.2K
- Earning Date
- DGII 11-12-2025
- HROW 11-12-2025
- Dividend Yield
- DGII N/A
- HROW N/A
- EPS Growth
- DGII 147.46
- HROW N/A
- EPS
- DGII 1.14
- HROW N/A
- Revenue
- DGII $420,935,000.00
- HROW $227,661,000.00
- Revenue This Year
- DGII $2.46
- HROW $45.86
- Revenue Next Year
- DGII $7.77
- HROW $41.41
- P/E Ratio
- DGII $33.06
- HROW N/A
- Revenue Growth
- DGII N/A
- HROW 47.69
- 52 Week Low
- DGII $22.39
- HROW $20.85
- 52 Week High
- DGII $38.54
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- DGII 68.72
- HROW 74.82
- Support Level
- DGII $35.01
- HROW $42.23
- Resistance Level
- DGII $36.94
- HROW $44.07
- Average True Range (ATR)
- DGII 1.15
- HROW 1.78
- MACD
- DGII 0.29
- HROW 0.54
- Stochastic Oscillator
- DGII 89.87
- HROW 98.79
About DGII Digi International Inc.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.